A question of choice: compliance in medicine taking

Third edition published by Medicines Partnership October 5^th  2005

This review, the first edition of which was published in June 2003, updates the most systematic review of compliance published by McGavock and colleagues in 1996 which showed that non-compliance was a serious issue affecting up to 50% of medicines prescribed for chronic conditions. Across the 13 specific disease areas (including coronary heart disease, epilepsy and diabetes) studied in the report, the evidence shows that non-compliance is still a major cause of unnecessary ill health and death. The evidence highlighted shows how much non-compliance is intentional and results from a considered decision made by patients, rather than just 'forgetfulness'.

This third edition includes a new chapter on medicines for psychotic conditions (kindly funded through an unrestricted educational grant from Janssen Cilag) and a chapter on asthma (kindly funded through an unrestricted educational grant from Serum), which were not in the first edition.

 The 3^rd edition can be downloaded in portable document format below.  

	A question of choice: Compliance in medicine taking 3rd Edition - full text in portable document format.

	A question of choice: Psychotic conditions Additional chapter on schizophrenia and bipolar disorder, in portable document format